Published in
International Institute of Anticancer Research, Anticancer Research, 10(36), p. 5053-5062
DOI: 10.21873/anticanres.11074
Links
Tools
Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment
Journal article published in 2016 by
James V. Michael 
,
Jeremy G. T. Wurtzel,
Lawrence E. Goldfinger
,
Jeremy G. T. Wurtzel,
Lawrence E. Goldfinger
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 